Penumbra, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PEN | 5187.T | TUO.F | 2190.HK | 0853.HK | 2160.HK | |
|---|---|---|---|---|---|---|
| Market cap | 12.71B | 8.84B | 21.09B | 6.45B | 11.62B | 1.63B |
| P/E (TTM) | 81.2 | 18.2 | 23.1 | 18.3 | — | — |
| Forward P/E | 52.3 | — | — | 11.4 | 23.3 | 37.9 |
| Price/book | 8.0 | 0.5 | 2.3 | 1.9 | 1.5 | 0.8 |
| Dividend yield | — | 4.33% | 1.53% | 1.30% | — | — |
| 1-year change | +21.86% | +10.47% | −5.43% | −18.44% | −46.33% | −77.54% |
| Today | +0.76% | +0.27% | +8.79% | +1.19% | 0.00% | 0.00% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All PEN news ›Factors Fueling Growth in the Intravenous Therapy and Vein Access Devices Market: Increasing Surgical Procedures Propel Market Expansion
Intravenous therapy and vein access devices have become essential components in modern healthcare supporting efficient medication delivery and patient care This market has experienced significant growth recently and is set to continue…
Critical Review: Penumbra (PEN) and Its Competitors
Posted by Tristan Rich on Nov 2nd, 2026 Penumbra (NYSE:PEN – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare Penumbra…
Penumbra (NYSE:PEN) Announces Quarterly Earnings Results
Posted by Michael Walen on Oct 31st, 2026 Get Our Latest Research Report on Penumbra Penumbra, Inc is a medical device company that develops, manufactures and markets products used to treat patients with vascular conditions. Its…
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
ALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026. Full Year 2026 Financial Outlook and…
Penumbra GAAP EPS of $1.07 misses by $0.11, revenue of $410.1M beats by $7.73M
Penumbra Q3 results: EPS missed, but revenue beat with 15.6% growth and strong thrombectomy sales. - Penumbra press release (PEN): Q3 GAAP EPS of $1.07 misses by $0.11. - Revenue of $410.1M (+15.6% Y/Y) beats by $7.73M. - Global…
Overturning Common Sense in Stroke and Acute Care: Does 'Hasty Lowering' of High Blood Pressure Kill Brain Cells? The Science of 'Permissive Hypertension' (220/120 Rule) to Save the Penumbra and Orthostatic Hypotension During Mobilization
"The blood pressure of a patient admitted for acute ischemic stroke is 180/100 mmHg! It's dangerous if they have a recurrence or cerebral hemorrhage, so we should immediately lower it to normal levels (below 130) with antihypertensive…
Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein…
Comparing Neogen (NASDAQ:NEOG) & Penumbra (NYSE:PEN)
Posted by Defense World Staff on Oct 19th, 2026 Neogen (NASDAQ:NEOG – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based…
Penumbra (NYSE:PEN) Stock Breaks Above 50-Day Moving Average – Should You Sell?
Posted by Defense World Staff on Oct 17th, 2026 Penumbra, Inc. (NYSE:PEN – Get Free Report)’s share price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $321.17 and traded as…
Penumbra Mezcal Launches
www.marketwatchmag.com Foley Family Wine & Spirits has launched Penumbra mezcal, the first agave-based spirit developed by Chip Tate, Foleyâs master distiller of innovation The mezcal ($45 a 750-ml.) is distilled from EspadÃn and…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com10
- defenseworld.net2
- seekingalpha.com2
- themarketsdaily.com2
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.